Michelle Shiller is currently the Medical Director of Molecular Pathology at Fulgent and the Medical Director of Precision Medicine and Genomics at the Texas Cancer Interception Institute/Baylor Sammons Cancer Center. Previously, they served as the Medical Director of Genetics at Baylor Scott & White Health and held various advisory roles, including with companies like Bristol-Myers Squibb and Merck. A thought leader in the integration of molecular diagnostics, Michelle has been an advocate for appropriate test utilization and multidisciplinary collaboration to enhance patient outcomes. They possess extensive experience in educating healthcare providers on the application of molecular genetic biomarkers and have been involved in developing comprehensive educational materials and programs to bridge knowledge gaps in genomic medicine.
This person is not in any teams
This person is not in any offices